Hauptseite > Publikationsdatenbank > In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer’s Disease > print

001     825309
005     20210129225257.0
024 7 _ |a 10.3233/JAD-160316
|2 doi
024 7 _ |a 1387-2877
|2 ISSN
024 7 _ |a 1875-8908
|2 ISSN
024 7 _ |a WOS:000389695700003
|2 WOS
024 7 _ |a altmetric:13358066
|2 altmetric
024 7 _ |a pmid:27802224
|2 pmid
037 _ _ |a FZJ-2016-07773
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dronse, Julian
|0 P:(DE-Juel1)162382
|b 0
|e Corresponding author
|u fzj
245 _ _ |a In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer’s Disease
260 _ _ |a Amsterdam
|c 2017
|b IOS Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1484217353_29815
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The clinical heterogeneity of Alzheimer’s disease is not reflected in the rather diffuse cortical deposition of amyloid-β. We assessed the relationship between clinical symptoms, in vivo tau pathology, amyloid distribution, and hypometabolism in variants of Alzheimer’s disease using novel multimodal PET imaging techniques. Tau pathology was primarily observed in brain regions related to clinical symptoms and overlapped with areas of hypometabolism. In contrast, amyloid-β deposition was diffusely distributed over the entire cortex. Tau PET imaging may thus serve as a valuable biomarker for the localization of neuronal injury in vivo and may help to validate atypical subtypes of Alzheimer’s disease.
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Fliessbach, Klaus
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Bischof, Gérard N.
|0 P:(DE-Juel1)166265
|b 2
|u fzj
700 1 _ |a von Reutern, Boris
|0 P:(DE-Juel1)156372
|b 3
700 1 _ |a Faber, Jennifer
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Hammes, Jochen
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Kuhnert, Georg
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 7
|u fzj
700 1 _ |a Onur, Oezguer A.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Kukolja, Juraj
|0 P:(DE-Juel1)131730
|b 9
|u fzj
700 1 _ |a van Eimeren, Thilo
|0 P:(DE-Juel1)169110
|b 10
|u fzj
700 1 _ |a Jessen, Frank
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 12
|u fzj
700 1 _ |a Klockgether, Thomas
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Drzezga, Alexander
|0 P:(DE-HGF)0
|b 14
773 _ _ |a 10.3233/JAD-160316
|g Vol. 55, no. 2, p. 465 - 471
|0 PERI:(DE-600)2070772-1
|n 2
|p 465 - 471
|t Journal of Alzheimer's disease
|v 55
|y 2017
|x 1875-8908
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/825309/files/jad%252F2017%252F55-2%252Fjad-55-2-jad160316%252Fjad-55-jad160316.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:825309
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)162382
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)166265
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131730
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)169110
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 12
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J ALZHEIMERS DIS : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a No Authors Fulltext
|0 StatID:(DE-HGF)0550
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-5-20090406

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21